| 产品详情 |
| Edit |   |
|---|
| Product Name | Benzyl (4-Oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate |
|---|
| Description | Benzyl (4-Oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate is an intermediate in the synthesis of Sitagliptin Triazecine Analog (S491015). Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes. Molecular Formula: C24H19F6N5O4 Solubility: Dichloromethane, Ethyl Acetate Molecular Weight: 555.42999999999995 |
|---|
| Size | 2.5mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Benzyl (4-Oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 442425 |
|---|
| Price | |
|---|
| Order / More Info | Benzyl (4-Oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|